Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Akebia Therapeutics, Inc. AKBA

Healthcare  —  Drug Manufacturers Specialty & Generic
0.90 (0.02) (2.17%) as of 25 Sep
Market cap
$254.7M
P/E
0.0×
Insider Buys (last 12m)
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio 1.75 2.50 1.22 0.39 1.77 1.32 2.23 1.54 3.59 0.00
P/FCF ratio 6.10 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.17
P/Operating CF 13.30 (89.74) (103.15) (2.07) (5.97) (12.59) (8.12) (4.35) (39.76) 4.14
P/B ratio 12.70 0.00 0.00 21.67 5.07 1.57 1.90 0.50 5.31 5.81
Price to Tangible BV 0.00 0.00 0.00 0.00 0.00 8.01 15.43 1.27 5.31 5.81
EV/Sales 1.25 2.53 1.18 0.30 1.94 0.88 2.03 1.11 1.84 0.00
EV/EBITDA 11.91 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Operating CF 4.34 (9.96) (9.83) (1.22) (1.62) (2.36) (2.65) (2.37) (5.94) 2.34
EV/FCF 4.35 (9.96) (9.78) (1.21) (1.62) (2.30) (2.58) (2.33) (5.77) 2.46
Quick Ratio 1.42 1.07 0.82 1.01 0.77 1.58 0.90 1.27 2.49 2.57
Current Ratio 1.55 1.41 1.18 1.43 1.04 1.98 1.49 1.76 2.54 2.59
Net Debt/EBITDA (5.51) 1.02 0.96 0.57 (0.15) 0.56 0.27 0.51 4.21 1.92
Debt/Assets 12.81% 17.53% 14.35% 18.56% 34.86% 15.74% 10.48% 1.51% 0.00% 0.00%
Debt/Equity 1.48 (0.79) (1.13) 12.63 2.49 0.41 0.20 0.02 0.00 0.00
Asset Turnover 0.79 0.69 0.65 0.66 0.36 0.42 0.38 0.31 0.55 0.01
Operating CF/Net income (12.72) 0.59 0.45 0.78 0.90 0.29 0.92 0.68 0.76 (0.43)
Capex/Depreciation (0.09) 0.00 0.00 0.00 0.00 0.00 (0.18) (1.35) (1.32) (3.37)
Interest Coverage 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE 64.49% 174.03% 409.60% (237.83%) (175.37%) (119.82%) (54.27%) (37.86%) (77.27%) (136.35%)
ROA (1.79%) (30.02%) (17.37%) (21.28%) (48.07%) (54.38%) (31.64%) (21.10%) (22.17%) (61.26%)
ROIC 0.00% 0.00% 0.00% 0.00% (152.01%) (196.30%) (54.53%) (20.38%) 0.00% 0.00%
Return on Tangible Assets (5.86%) (197.65%) (237.01%) (154.82%) (1,673.53%) (199.49%) (250.15%) (68.18%) (33.36%) (73.51%)
Average Days of Receivables 72.68 78.31 73.69 50.27 88.95 82.81 42.61 410.54 68.91 8,042.60
Research and Development Expense of Revenue 26.40% 23.51% 32.41% 44.44% 69.86% 74.15% 96.41% 140.08% 127.41% 7,543.00%
Selling, General and Administrative Expense of Revenue 45.50% 66.52% 51.50% 47.39% 82.28% 52.30% 44.61% 41.91% 14.90% 1,446.91%
Intangible Assets out of Total Assets 0.16 0.27 0.39 0.37 0.32 0.31 0.45 0.38 0.00 0.00
Share Based Compensation of Revenue 4.78% 4.85% 4.79% 6.10% 10.74% 8.30% 3.56% 9.17% 4.89% 379.48%
Graham Net Nets (0.22) (0.39) (0.65) (1.46) (0.49) (0.06) (0.09) 0.34 0.18 0.16
Graham Number 0.00 1.32 1.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield (1.06%) (17.37%) (22.05%) (82.26%) (75.22%) (98.93%) (37.34%) (44.67%) (12.76%) (34.29%)
Free Cash Flow Yield 16.39% (10.15%) (9.87%) (64.65%) (67.46%) (29.28%) (35.29%) (30.88%) (8.87%) 13.95%
Revenue per Share 0.92 0.76 1.04 1.60 1.28 2.13 2.83 3.58 4.17 0.04
Operating CF per Share 0.26 (0.19) (0.12) (0.40) (1.52) (0.80) (2.17) (1.68) (1.29) 1.54
Capex per Share 0.00 0.00 0.00 0.00 0.00 0.00 (0.06) (0.03) (0.04) (0.07)
Free Cash Flow per Share 0.26 (0.19) (0.12) (0.40) (1.52) (0.80) (2.23) (1.71) (1.33) 1.46
Cash per Share 0.72 0.25 0.23 0.49 0.90 1.65 1.25 1.80 7.31 6.90
Shareholders Equity per Share 0.13 (0.23) (0.16) 0.03 0.45 1.79 3.33 10.96 2.82 1.81
Interest Debt per Share 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share 0.13 (0.23) (0.16) 0.03 0.45 1.79 3.33 10.96 2.82 1.81
Free Cash Flow 67.87 (40.69) (23.38) (73.27) (253.02) (110.70) (264.10) (99.10) (57.78) 55.24
Working Capital 90.02 32.92 18.28 55.65 10.10 184.29 101.42 202.58 217.25 182.05
Capital Expenditures (0.12) (0.03) — (0.11) (0.06) (0.32) (6.65) (1.61) (1.62) (2.66)
Net Current Asset Value (91.00) (156.02) (154.14) (165.64) (184.19) (25.08) (66.91) 107.66 116.68 64.23
EV/EBIT 12.55 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.01 0.01 1.73
Net Profit Margin (2.26%) (43.33%) (26.68%) (32.22%) (133.25%) (130.61%) (83.48%) (69.12%) (40.65%) (8,843.45%)
Price to Operating Income 17.62 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets 1.04 17.05 10.37 7.23 5.62 17.29 3.64 0.15 0.34 0.30
Cash ROIC 25.13% (103.58%) (57.45%) (48.44%) (63.60%) (20.60%) (42.99%) (13.97%) (13.57%) 16.83%
Accounts Receivable Turnover 5.80 4.35 4.89 6.37 3.57 5.56 2.46 1.55 5.33 0.09
Accounts Payable Turnover 2.17 4.24 4.54 3.32 4.02 4.52 3.54 0.31 0.14 0.00
Inventory Turnover 2.48 3.96 3.98 2.94 3.09 2.05 1.26 0.07 0.00 —
Average Days of Payables 195.95 87.70 72.04 76.87 81.37 82.82 98.49 2,010.88 4,139.82 0.00
Days of Inventory on Hand 144.38 93.84 77.24 92.00 88.73 122.33 292.20 5,368.10 0.00 —
Average Receivables 40.70 36.83 39.79 45.93 59.21 52.98 136.39 133.94 34.02 16.98
Average Payables 18.18 14.91 16.33 25.80 37.45 40.26 41.01 24.90 4.52 2.18
Average Inventory 15.93 15.97 18.63 29.10 48.82 88.68 115.30 115.00 — —
Average Assets 298.62 231.19 298.88 442.70 586.74 707.67 883.87 680.39 332.23 221.58
Average Common Equity (8.29) (39.88) (12.68) 39.62 160.81 321.19 515.34 379.25 95.35 99.56

Fold the line items

Columns are period end dates